As the federal Sunshine Act has rolled out over the last year, Minnesota has been one of the few states that has added additional reporting requirements for drug (not device) manufacturers to track. By May 1, 2015, drug manufacturers must report on their 2014 transfers of value made to physician assistants, APRNs, dental therapists, and veterinarians. These entities are excluded from the Federal reporting obligations. This week, Minnesota has released its reporting payment template.
The reportable elements include:
- First and Last Name of Practitioner;
- Professional Designation;
- Address of Practitioner; and
- Payment Information, including fields for Value of Payment and Specific Reason for Payment.
Minnesota Statute 151.252 states that drug manufacturers must file an annual report identifying all payments, honoraria, reimbursement, or other compensation paid to practitioners in Minnesota during the preceding calendar year. The report must identify the nature and value of any payments totaling $100 or more to a particular practitioner during the year, and must identify the practitioner.
According to the new law in Minnesota (page 189 of the PDF; 9535 of the bill), "Practitioner" means a licensed doctor of medicine, licensed doctor of osteopathy duly licensed to practice medicine, licensed doctor of dentistry, licensed doctor of optometry, licensed podiatrist, or licensed veterinarian. The statute now states that for purposes of the disclosure law, "practitioner" redefined to include a physician assistant authorized to prescribe, dispense, and administer under chapter 147A, or an advanced practice nurse authorized to prescribe, dispense, and administer under section 148.235, and dental therapist authorized to dispense and administer under chapter 150A.